Is a complete TPEX/7731 research report available?

No complete published report is available for tpex/7731 (TPEX/7731) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/7731 stock profile: metrics, valuation and analysis

Market cap	2.2B
Revenue (ttm)	584.7M
Net income (ttm)	32M
EPS (ttm)	NT$0.06
Shares out	522M
P/E (trailing)	70.9x
Dividend	NT$0.06 (1.34%)
Volume	646,606
Beta	0.72

All TPEX/7731 indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

TWD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	80
Employees Change	62%
Employees Change Percent	344.4
Enterprise value	TWD 2.4B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Isin	TW0007731002
Last refreshed	2026-09-12
Market cap	TWD 2.2B
Price	TWD 4.39
Price currency	TWD
Sector	Healthcare
Sector PE	88.31
Sector PE Fwd	27.72
Sic	5912
Symbol	tpex/7731
Website	https://marxbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.43%
EV Earnings	74.38x
EV/Sales	4.07x
FCF yield	-6.45%
P/B ratio	7.74x
P/E ratio	70.87x
P/S ratio	3.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-26.12%
EBITDA Margin	-24.27%
Gross margin	50.79%
Gross Profit	TWD 297M
Gross Profit Growth	-38.85%
Gross Profit Growth Q	-45.12%
Gross Profit Growth3 Y	45.97%
Net Income	TWD 32M
Net Income Growth Years	1%
Net Income Growth3 Y	54.83%
Pretax Margin	8.3%
Profit Margin	5.47%
Profitable Years	1
ROA	-13.57
ROCE	-34.78
ROE	12.45
ROIC	-22.62
Roic5y	-14.09

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	10.36%
EPS Growth Years	1
EPS Growth3 Y	36.09
Revenue Growth	-17.97x
Revenue Growth Q	-16.55x
Revenue Growth Qo Q	-21.14x
Revenue Growth Quarters	3x
Revenue Growth Years	4x
Revenue Growth3 Y	67.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.83
Assets	TWD 674.4M
Cash	TWD 73.3M
Current Assets	TWD 391.5M
Current Liabilities	TWD 235.1M
Debt	TWD 220M
Debt Equity	TWD 0.76
Debt FCF	TWD -1.53
Equity	TWD 288.6M
Interest Coverage	-13.8
Liabilities	TWD 385.8M
Long Term Assets	TWD 282.9M
Long Term Liabilities	TWD 150.6M
Net Cash	TWD -146.7M
Net Cash By Market Cap	TWD -6.57
Net Debt Equity	TWD 0.51
Tangible Book Value	TWD 222.6M
Tangible Book Value Per Share	TWD 0.43
WACC	7.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.67
Inventory Turnover	1.67
Net Working Capital	TWD 153.6M
Quick ratio	1.13
Working Capital	TWD 156.4M
Working Capital Turnover	TWD 5.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.53%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	TWD 0.06
Dividend Years	1
Dividend Yield	1.34%
Ex Div Date	2026-08-28
Last Dividend	TWD 0.06

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	10.35%
200-day SMA	5.3
50-day SMA	4.68
50-day SMA vs 200-day SMA	50under200
All Time High	15.5
All Time High Change	-71.68%
All Time High Date	2024-03-05
All Time Low	3.9
All Time Low Change	12.56%
All Time Low Date	2024-02-05
ATR	0.24
Beta	0.72
Beta1y	0.12
Beta2y	0.33
Ch YTD	-8.92
High	4.5
High52	10.6
High52 Date	2026-01-26
High52ch	-58.58%
Low	4.03
Low52	3.9
Low52 Date	2025-09-15
Low52ch	12.56%
Ma50ch	-6.12%
Price vs 200-day SMA	-17.15%
RSI	38.35
RSI Monthly	32.17
RSI Weekly	40.08
Sharpe ratio	0.29x
Sortino ratio	0.77
Total Return	-4.2%
Tr YTD	-7.73
Tr1m	-5.78%
Tr1w	1.62%
Tr3m	-20.87%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	352,905,938%
Net Borrowing	-147,308,000
Shares Insiders	22.5%
Shares Out	521,981,000
Shares Qo Q	-3.07%
Shares Yo Y	5.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -144.5M
Adjusted OCF	-140,948,000
Average Volume	560,792.85x
Bv Per Share	0.55
CAPEX	TWD -3.6M
Ch1m	-6.99
Ch1w	1.62
Ch1y	8.93
Ch3m	-21.89
Ch6m	-19.74
Change	3.29%
Change From Open	1.15
Close	4.25
Days Gap	2.12
Depreciation Amortization	10,843,000
Dollar Volume	2,838,600.3
Earnings Date	2026-11-13
EBIT	TWD -152.7M
EBITDA	TWD -141.9M
EPS	TWD 0.06
F Score	3
FCF	TWD -144.1M
FCF EV Yield	-6.05x
FCF Per Share	TWD -0.28
Financing CF	7,414,000
Fiscal Year End	December
Founded	2,015
Goodwill	20,879,000
Graham Number	0.86679
Graham Upside	-80.26
Income Tax	TWD 17.2M
Investing CF	183,971,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2026-06-30
Last Split Date	2024-07-11
Last Split Type	Forward
Lynch Fair Value	TWD 1.51
Lynch Upside	-65.61
Ma150	5.44
Ma150ch	-19.32%
Ma20	4.38
Ma20ch	0.32%
Net CF	50,854,000
Next Earnings Date	2026-11-13
Open	4.34
Payment Date	2026-09-23
Position In Range	76.6
Ppne	209,526,000
Price Date	2026-09-11
Ptbv Ratio	10.03
Relative Volume	1.16x
Revenue	584,740,000x
SBC By Revenue	0.07x
Share Based Comp	417,000
Tax By Revenue	2.95x
Tax Rate	35.54%
Tr6m	-18.7%
Volume	646,606
Z Score	4.39

TPEX/7731 (TPEX/7731)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/7731

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/7731 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/7731

Frequently asked questions